 | • レポートコード：MRC-IM30298 • 出版社/出版日：IMARC / 2022年11月 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥359,856 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥647,856 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2021年に683.45百万ドルであった世界の口腔乾燥症（ドライマウス）治療薬市場規模が、2022年から2027年の間にCAGR 3.75％で成長し、2027年までに862.79百万ドルに達すると予測しています。本調査レポートでは、口腔乾燥症（ドライマウス）治療薬の世界市場について総合的に調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、種類別（人工唾液＆唾液代替物、唾液刺激剤）分析、薬剤タイプ別（OTC薬、処方薬）分析、流通チャネル別（病院薬局、小売薬局、オンライン薬局）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目をまとめています。なお、本書に掲載されている企業情報には、3M Company, Biotene (GSK plc), Parnell Pharmaceuticals Inc., Quest Products LLC, Saliwell Ltd, Sun Pharmaceutical Industries Limited and West-Ward Pharmaceutical (Hikma Pharmaceuticals plc)などが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界の口腔乾燥症（ドライマウス）治療薬市場規模：種類別 - 人工唾液＆唾液代替物の市場規模 - 唾液刺激剤の市場規模 ・世界の口腔乾燥症（ドライマウス）治療薬市場規模：薬剤タイプ別 - OTC薬の市場規模 - 処方薬の市場規模 ・世界の口腔乾燥症（ドライマウス）治療薬市場規模：流通チャネル別 - 病院薬局チャネルの市場規模 - 小売薬局チャネルの市場規模 - オンライン薬局チャネルの市場規模 ・世界の口腔乾燥症（ドライマウス）治療薬市場規模：地域別 - 北米の口腔乾燥症（ドライマウス）治療薬市場規模 - アジアの口腔乾燥症（ドライマウス）治療薬市場規模 - 欧州の口腔乾燥症（ドライマウス）治療薬市場規模 - 中南米の口腔乾燥症（ドライマウス）治療薬市場規模 - 中東・アフリカの口腔乾燥症（ドライマウス）治療薬市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global xerostomia (dry mouth disease) therapeutics market size reached US$ 683.45 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 862.79 Million by 2027, exhibiting a growth rate (CAGR) of 3.75% during 2022-2027.
Xerostomia, or dry mouth, refers to symptoms or sensations of oral dryness that are usually caused due to a decrease in the amount of saliva. This condition is triggered by the adverse effects of radioactivity in the neck and head, increasing consumption of antianxiety drugs, dehydration, diabetes, and Alzheimer’s disorder. It can be treated with the support of salivary pens or stimulants, artificial saliva, prescribed medications, and home remedies, including sipping water and moisturizing lips. Apart from this, the early diagnosis of salivary glands by practitioners and the usage of recommended mouth moisturizing products, such as over-the-counter (OTC) rinsing, can assist in lubricating the mouth. These treatments alleviate discomfort, prevent severe complications, fix taste disorders, and mitigate bad breath and taste disorders. Consequently, xerostomia therapeutics are used across several hospitals and clinics to deal with decreased salivary gland function.
Xerostomia (Dry Mouth Disease) Therapeutics Market Trends:
The increasing incidences of dry mouth, especially amongst the geriatric population, due to medicine side-effects of radiotherapy and chemotherapy and the rising need for dry mouth relief products are primarily driving the market growth. Additionally, the growing uptake of several prescription-based toothpaste, vitamin gummies, and medicines for treating Sjogren’s syndrome, Alzheimer’s diseases, and human immunodeficiency virus (HIV) that cause xerostomia is acting as another growth-inducing factor. In line with this, the rising consumer awareness regarding the early diagnosis of xerostomia, significant enhancements in healthcare expenditure, and the advent of diverse diagnostic technologies are propelling the market growth. Moreover, the favorable initiatives being commenced by governments to sensitize consumers regarding the xerostomia disease, its symptoms, causes, and treatments are impelling the market growth. Apart from this, the easy availability of various therapeutic drugs and ongoing research and development (R&D) activities are creating a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global xerostomia (dry mouth disease) therapeutics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, drug type and distribution channel.
Breakup by Type:
Artificial Saliva/Saliva Substitutes
Salivary Stimulants
Breakup by Drug Type:
OTC
Prescription
Breakup by Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Biotene (GSK plc), Parnell Pharmaceuticals Inc., Quest Products LLC, Saliwell Ltd, Sun Pharmaceutical Industries Limited and West-Ward Pharmaceutical (Hikma Pharmaceuticals plc).
Key Questions Answered in This Report:
How has the global xerostomia (dry mouth disease) therapeutics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global xerostomia (dry mouth disease) therapeutics market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the drug type?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global xerostomia (dry mouth disease) therapeutics market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Xerostomia (Dry Mouth Disease) Therapeutics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Artificial Saliva/Saliva Substitutes
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Salivary Stimulants
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Drug Type
7.1 OTC
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Prescription
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacy
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Pharmacy
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 3M Company
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Biotene (GSK plc)
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Parnell Pharmaceuticals Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Quest Products LLC
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Saliwell Ltd
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Sun Pharmaceutical Industries Limited
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 West-Ward Pharmaceutical (Hikma Pharmaceuticals plc)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
Figure 2: Global: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Xerostomia Therapeutics Market: Breakup by Type (in %), 2021
Figure 5: Global: Xerostomia Therapeutics Market: Breakup by Drug Type (in %), 2021
Figure 6: Global: Xerostomia Therapeutics Market: Breakup by Distribution Channel (in %), 2021
Figure 7: Global: Xerostomia Therapeutics Market: Breakup by Region (in %), 2021
Figure 8: Global: Xerostomia Therapeutics (Artificial Saliva/Saliva Substitutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Xerostomia Therapeutics (Artificial Saliva/Saliva Substitutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Xerostomia Therapeutics (Salivary Stimulants) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Xerostomia Therapeutics (Salivary Stimulants) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Xerostomia Therapeutics (OTC) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Xerostomia Therapeutics (OTC) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Xerostomia Therapeutics (Prescription) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Xerostomia Therapeutics (Prescription) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Xerostomia Therapeutics (Hospital Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Xerostomia Therapeutics (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Xerostomia Therapeutics (Retail Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Xerostomia Therapeutics (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Xerostomia Therapeutics (Online Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Xerostomia Therapeutics (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: North America: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: North America: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: United States: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: United States: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Canada: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Canada: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Asia-Pacific: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Asia-Pacific: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: China: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: China: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Japan: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Japan: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: India: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: India: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: South Korea: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: South Korea: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Australia: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Australia: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Indonesia: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Indonesia: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Others: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Others: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Europe: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Europe: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Germany: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Germany: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: France: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: France: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: United Kingdom: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: United Kingdom: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Italy: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Italy: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Spain: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Spain: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Russia: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Russia: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Others: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Others: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Latin America: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Latin America: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Brazil: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Brazil: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Mexico: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Mexico: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Others: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Others: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Middle East and Africa: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Middle East and Africa: Xerostomia Therapeutics Market: Breakup by Country (in %), 2021
Figure 70: Middle East and Africa: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Global: Xerostomia Therapeutics Industry: SWOT Analysis
Figure 72: Global: Xerostomia Therapeutics Industry: Value Chain Analysis
Figure 73: Global: Xerostomia Therapeutics Industry: Porter's Five Forces Analysis
• 日本語訳：口腔乾燥症（ドライマウス）治療薬の世界市場：動向・シェア・規模・予測
• レポートコード：MRC-IM30298 ▷ お問い合わせ（見積依頼・ご注文・質問）